Urolithin A shows effective against muscular dystrophy Research EPFL A new study published in Science Translational Medicine by EPFL professor Johan Auwerx and scientists from EPFL start-up Amazentis highlights the effectiveness of mitophagy-stimulating molecule Urolithin A in mice to cure a disease similar to Duchenne Muscular Dystrophy. And points to a possible treatment for affected people. Insight into tumour samples Research ETH Zurich Bernd Bodenmiller studies the mechanisms of cancer development. The quantitative biologist uses 3D analysis and virtual reality to detect groups of cells that break away from tumours. Animal experiments still play a key role Politics ETH Zurich Without animal experiments there would be no COVID-19 vaccine: animal testing is essential for medical research. A ban on testing – even a gradual phase-out – would be extremely damaging for research policy, writes Detlef Günther. Cancer: a new killer lymphocyte enters the ring Research EPFL A team from EPFL and the Swiss Cancer Center Léman has discovered that CD4 T lymphocytes, which usually play a supporting role in fighting cancer cells, also have the power to destroy them. Scientists model a peculiar type of breast cancer Research EPFL Scientists led by EPFL have developed a breakthrough in vivo model for invasive lobular carcinoma, a serious yet understudied type of breast cancer. The work will open up previously inaccessible study of the tumor’s biology and help discover new therapies. Previous 30 31 32 33 34 35 36 37 Page 37 of 37
